However, in AML, mutations affecting genes encoding tyrosine kinase receptor (FLT3 and KIT), genes involved in the RAS pathway, and genes like CEBPA, NPM1 and IDH1/IDH2 are over-represented compared to MDS. This evidence concerns the gene IDH2 and myelodysplastic syndrome.